Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I. (Record no. 9721476)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01385 a2200373 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250513152658.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 199810s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0039-2499 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1161/01.str.29.10.2073 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Hacke, W |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 19981030 |
| 245 00 - TITLE STATEMENT | |
| Title | Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Stroke |
| Date of publication, distribution, etc. | Oct 1998 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2073-5 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cerebrovascular Disorders |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | National Institutes of Health (U.S.) |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Outcome Assessment, Health Care |
| General subdivision | statistics & numerical data |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Plasminogen Activators |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Retrospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tissue Plasminogen Activator |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | United States |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bluhmki, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Steiner, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tatlisumak, T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mahagne, M H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sacchetti, M L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Meier, D |
| 773 0# - HOST ITEM ENTRY | |
| Title | Stroke |
| Related parts | vol. 29 |
| -- | no. 10 |
| -- | p. 2073-5 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1161/01.str.29.10.2073">https://doi.org/10.1161/01.str.29.10.2073</a> |
| Public note | Available from publisher's website |
No items available.